The Clinical Outcomes and Pharmacovigilance WG is focused on research around adverse events among persons treated and untreated with HIV/AIDS in IeDEA. This Working Group consists of a representative from each IeDEA region, as well as program staff from DAIDS.
- To optimize the aggregation of data on adverse events at IeDEA sites to allow for meaningful research on adverse events in diverse populations and across IeDEA regions.
- To work within IeDEA, and with global partners, to develop a pharmacovigilence system at IeDEA sites to describe the incidence and prevalence of adverse events among persons receiving care.
- To identify risk factors for adverse events.
- To conduct research on the clinical management of adverse events in diverse patient populations